Repinex - Materials

About Patientadmin2024-01-30T14:12:17+00:00

THIS PAGE IS INTENDED FOR UK PATIENTS WHO HAVE BEEN PRESCRIBED REPINEX XL

About Repinex XL

Repinex® XL Patient Information
This link will take you to the electronic Medicines Compendium (eMC) website.

Repinex® XL Patient Information

Repinex® XL Summary of Product Characteristics
These links will take you to the electronic Medicines Compendium (eMC) website:

2mg prolonged-release tablets:

4mg prolonged-release tablets:

8mg prolonged-release tablets:

Parkinson’s Disease Resources

Please click the links below to leave the Aspire Pharma website. Aspire are not responsible for the content of external sites.

TRUSTED BRANDS.
DEPENDABLE SUPPLY CHAIN.

For further information please call: 01730 231148,
email: [email protected] or visit www.aspirepharma.co.uk

Reporting of Side Effects
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the product’s package leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard. By reporting side effects you can help provide more information on the safety of this medicine.

Revision reference – Repinex XL_24_01.02.2024

On this website we use first or third-party tools that store small files (cookies) on your device. Cookies are normally used to allow the site to run properly (technical cookies), to generate navigation usage reports (statistics cookies) and to advertise our services/products (profiling cookies). We can directly use technical cookies, but you have the right to choose whether or not to enable statistical and profiling cookies. Enabling these cookies, you help us to offer you a better experience.